Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 Biomarker disease BEFREE miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment. 28981169 2018
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 Biomarker disease BEFREE MicroRNA-200c suppresses tumor metastasis in oral squamous carcinoma by inhibiting epithelial-mesenchymal transition. 29917193 2018
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 AlteredExpression disease BEFREE Serum levels of miR-200c can been used to effectively distinguish oral squamous cell carcinoma patients from healthy control, and patients with lower serum level of miR-200c showed shorter survival time. miR-200c overexpression inactivated Akt and Glut1 expression, while Akt activator and Glut1 overexpression showed no significant effects on miR-200c. 30179745 2018
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 Biomarker disease BEFREE Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction. 26879838 2017
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 Biomarker disease BEFREE We used quantitative real-time polymerase chain reaction (PCR) to compare relative expression of miR-21, miR-141, and miR-200c in 70 formalin-fixed, paraffin-embedded samples of sinonasal carcinoma tissue (majority of squamous cell carcinoma [SCC] samples) with 17 control samples of sinonasal tissue. 28960576 2017
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 AlteredExpression disease BEFREE High miR-200c (p = 0.0004) and miR-141 (p = 0.009) expression correlated with shorter OS in adenocarcinoma - but not in SCC. 25003366 2014
Entrez Id: 406985
Gene Symbol: MIR200C
MIR200C
0.070 PosttranslationalModification disease BEFREE Aberrant miR-375 and miR-200a expression and miR-200c-141 methylation could be detected in and distinguish OSCC patient oral rinse and saliva from healthy volunteers, suggesting a potential clinical application for OSCC specific miRNA signatures in oral fluids. 22132151 2011